Bayer responds to CCI queries on Monsanto deal

In India, the integration process is subject to approvals from CCI

Bayer's bid for Monsanto is complementary

German drugs and agrochemicals company Bayer said it had replied to queries raised by the Competition Commission of India (CCI) on the possible implications for this country's agricultural biotechnology sector

Also Read

CCI expands leniency norms to individuals

Bayer Crop Science eyes double-digit growth in India: Peter R Mueller

Bayer, Monsanto likely to extend merger deadline

SC rejects CCI order against GSK, Sanofi

Monsanto, Bayer CropScience cut India investments

Make in India: Govt wants Apple to come out with a 'workable solution'

Options to revive group drying up for Anil Ambani

Chinese firms raise interest in Indian durables

JSW prepares war chest to bid for toxic assets

Predictive messages about Indian cos results circulate in WhatsApp groups

First Published: Nov 17 2017 | 1:26 AM IST

Explore News

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on are available only to BS Premium subscribers.

Register to